Improving Facial Fat Graft Survival Using Stromal Vascular Fraction-Enriched Lipotransfer: A Multicenter Randomized Controlled Study

被引:2
|
作者
Wufuer, Maierdanjiang [1 ]
Choi, Tae Hyun [3 ]
Najmiddinov, Bakhtiyor [4 ]
Kim, Junhyung [5 ]
Choi, Jaehoon [5 ]
Kim, Taeyoung [6 ]
Park, Yongsoo [6 ]
Kim, Ji-hoon [2 ]
Jeon, Heejung [1 ]
Kim, Byung Jun [1 ]
机构
[1] Seoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Dept Plast & Reconstruct Surg, 101 Daehak Ro, Seoul 03080, South Korea
[2] Seoul Natl Univ, Seoul Natl Univ Hosp, Dept Radiol, Coll Med, Seoul, South Korea
[3] THENEVUS Plast Surg Clin, Seoul, South Korea
[4] Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Plast & Reconstruct Surg, Seoul, South Korea
[5] Keimyung Univ, Sch Med, Dept Plast & Reconstruct Surg, Daegu, South Korea
[6] VEStech, Alfred, Australia
关键词
MESENCHYMAL STEM-CELLS; AUTOLOGOUS FAT; ASSISTED LIPOTRANSFER; BREAST AUGMENTATION; VOLUME RETENTION; RECIPIENT SITES; SKIN QUALITY; THERAPY; INDUCTION; SCARS;
D O I
10.1097/PRS.0000000000010625
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Although previous clinical studies have reported that cell-assisted lipotransfer increases the fat survival rate in facial fat transplants, most were case studies without quantitative evaluation. A multicenter randomized controlled study was performed to evaluate the safety and efficacy of the stromal vascular fraction (SVF) in facial fat grafts. Methods: Twenty-three participants were enrolled for autologous fat transfer in the face, and assigned randomly to the experimental (n = 11) or control (n = 12) group. Fat survival was assessed using magnetic resonance imaging at 6 and 24 weeks postoperatively. Subjective evaluations were performed by the patients and surgeons. To address safety concerns, results of an SVF culture and the postoperative complications were recorded. Results: The overall fat survival rate was significantly higher in the experimental group than in the control group (6 weeks, 74.5% +/- 9.99% versus 66.55% +/- 13.77%, P < 0.025; 24 weeks, 71.27% +/- 10.43% versus 61.98% +/- 13.46%, P < 0.012). Specifically, graft survival in the forehead was 12.82% higher in the experimental group when compared with that in the control group at 6 weeks (P < 0.023). Furthermore, graft survival in the forehead (P < 0.021) and cheeks (P < 0.035) was superior in the experimental group at 24 weeks. At 24 weeks, the aesthetic scores given by the surgeons were higher in the experimental group than in the control group (P < 0.03); however, no significant intergroup differences were noted in the patient-evaluated scores. Neither bacterial growth from SVF cultures nor postoperative complications were noted. Conclusion: SVF enrichment for autologous fat grafting can be a safe and effective technique for increasing the fat retention rate.
引用
收藏
页码:690e / 700e
页数:11
相关论文
共 39 条
  • [31] Adipose Tissue-Derived Stromal Vascular Fraction Plus Fat Grafts for Hand Therapy in Patients with Systemic Sclerosis. a Randomized Controlled Clinical Trial
    Iglesias, Martin
    Torre-Villalvazo, Ivan
    Tovar-Palacio, Armando
    Zentella-Dehesa, Alejandro
    Butron-Gandarillas, Patricia
    Durand-Carbajal, Marta
    Torre-Anaya, Erik
    Guevara, Martha
    Rodriguez-Reyna, Tatiana
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 2862 - 2863
  • [32] Intra-Articular Injection of Adipose-Derived Stromal Vascular Fraction in Osteoarthritic Temporomandibular Joints: Study Design of a Randomized Controlled Clinical Trial
    Schipper, Jan Aart M.
    Tuin, Aartje Jorien
    van Dongen, Joris A.
    van Bakelen, Nico B.
    Harmsen, Martin Conrad
    Spijkervet, Fred K. L.
    BIOENGINEERING-BASEL, 2024, 11 (02):
  • [33] Oncological safety of stromal vascular fraction enriched fat grafting in two-stage breast reconstruction after nipple sparing mastectomy: long-term results of a prospective study
    Calabrese, C.
    Kothari, A.
    Badylak, S.
    Di Taranto, G.
    Marcasciano, M.
    Sordi, S.
    Barellini, L.
    Lo Torto, F.
    Tarallo, M.
    Gaggelli, I
    D'Ermo, G.
    Fausto, A.
    Casella, D.
    Ribuffo, D.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2018, 22 (15) : 4768 - 4777
  • [34] A prospective, non-randomized, no placebo-controlled, phase Ib clinical trial to study the safety of the adipose derived stromal cells-stromal vascular fraction in idiopathic pulmonary fibrosis
    Tzouvelekis, Argyris
    Paspaliaris, Vassilis
    Koliakos, George
    Ntolios, Paschalis
    Bouros, Evangelos
    Oikonomou, Anastasia
    Zissimopoulos, Athanassios
    Boussios, Nikolaos
    Dardzinski, Brian
    Gritzalis, Dimitrios
    Antoniadis, Antonis
    Froudarakis, Marios
    Kolios, George
    Bouros, Demosthenes
    JOURNAL OF TRANSLATIONAL MEDICINE, 2013, 11
  • [35] A prospective, non-randomized, no placebo-controlled, phase Ib clinical trial to study the safety of the adipose derived stromal cells-stromal vascular fraction in idiopathic pulmonary fibrosis
    Argyris Tzouvelekis
    Vassilis Paspaliaris
    George Koliakos
    Paschalis Ntolios
    Evangelos Bouros
    Anastasia Oikonomou
    Athanassios Zissimopoulos
    Nikolaos Boussios
    Brian Dardzinski
    Dimitrios Gritzalis
    Antonis Antoniadis
    Marios Froudarakis
    George Kolios
    Demosthenes Bouros
    Journal of Translational Medicine, 11
  • [36] Evaluating the effectiveness of stromal-vascular fraction (SVF) cells along with subcision method in the treatment of acne scars: A double-blind randomized controlled clinical trial study
    Roohaninasab, Masoumeh
    Seifadini, Azadeh
    Atefi, Najmolsadat
    Sadeghzadeh-Bazargan, Afsaneh
    Goodarzi, Azadeh
    Hanifnia, Amir Reza
    Nouri, Maryam
    Zare, Sona
    Moradi, Sepideh
    Dehghani, Abbas
    Nilforoushzadeh, Mohammad Ali
    Behrangi, Elham
    JOURNAL OF COSMETIC DERMATOLOGY, 2022, 21 (12) : 6928 - 6938
  • [37] Effects of traditional Chinese medicine combined with chemotherapy for extensive-stage small-cell lung cancer patients on improving oncologic survival: study protocol of a multicenter, randomized, single-blind, placebo-controlled trial
    Yuyi Chen
    Mingwei Yu
    Zishen Liu
    Yi Zhang
    Qiwei Li
    Guowang Yang
    Trials, 22
  • [38] Effects of traditional Chinese medicine combined with chemotherapy for extensive-stage small-cell lung cancer patients on improving oncologic survival: study protocol of a multicenter, randomized, single-blind, placebo-controlled trial
    Chen, Yuyi
    Yu, Mingwei
    Liu, Zishen
    Zhang, Yi
    Li, Qiwei
    Yang, Guowang
    TRIALS, 2021, 22 (01)
  • [39] Phase II Multicenter, Randomized, Double-Blind Controlled Study of Efficacy and Safety of Umbilical Cord-Derived Mesenchymal Stromal Cells in the Prophylaxis of Chronic Graft-Versus-Host Disease After HLA-Haploidentical Stem-Cell Transplantation
    Gao, Lei
    Zhang, Yanqi
    Hu, Baoyang
    Liu, Jia
    Kong, Peiyan
    Lou, Shifeng
    Su, Yi
    Yang, Tonghua
    Li, Huimin
    Liu, Yao
    Zhang, Cheng
    Gao, Li
    Zhu, Lidan
    Wen, Qin
    Wang, Ping
    Chen, Xinghua
    Zhong, Jiangfan
    Zhang, Xi
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (24) : 2843 - +